The Filing Desk

Milestone Scientific vs Nexgel

Milestone Scientific MLSS · Nexgel NXGL · Health Care Equipment

Nexgel reported revenue of $11 million in fiscal 2025, 1.3 times Milestone Scientific's $9 million in fiscal 2025. Milestone Scientific's revenue grew 4.0% in its latest year, and Nexgel's grew 31.5%. Milestone Scientific had an operating margin of -63.5%, against -29.4% at Nexgel. Free cash flow was −$3 million at Milestone Scientific and −$1 million at Nexgel.

Side by side

Milestone ScientificNexgel
Latest fiscal yearFY2025, Dec 31, 2025FY2025, Dec 31, 2025
Revenue$9M$11M
Revenue growth4.0%31.5%
Revenue growth a year, last 5 years10.8%74.7%
Gross margin71.4%39.5%
Operating margin−63.5%−29.4%
Net margin−63.8%−26.3%
Free cash flow−$3M−$1M
Free cash flow margin−32.7%−12.1%
Return on capital——
Net debt to EBITDA——
Dividends and buybacks$0M$0M
Change in diluted share count2.9%20.6%
Last close$0.24$3.35
P/E at the last close——
Insider trades, last 12 months——
Piotroski F-score——
Amounts in each company's own currency, US$ unless marked (a foreign company may report in another), each company's latest fiscal year from its 10-K, or 20-F or 40-F for a foreign company. Growth rates compare with the year before; the five-year rate is the average a year. Free cash flow is cash from operations minus capital spending; return on capital is after-tax operating income over the money invested in the business; P/E is the last close over the latest earnings per share. Banks are measured differently (return on equity, efficiency ratio), so some rows apply to one company only.

Ten years

Revenue
US$ billions, fiscal years
Milestone ScientificNexgel
Operating margin
Percent of revenue
Milestone ScientificNexgel
Free cash flow
US$ billions. Cash from operations minus capital expenditure.
Milestone ScientificNexgel

Start a new comparison

Source: the companies' Form 10-K filings, from SEC EDGAR, and the last close. For information only, not investment advice: the figures describe results, not which company is the better investment. The Filing Desk is not affiliated with either company. Full figures on the Milestone Scientific and Nexgel pages.